Tomotherapy concomitant with cetuximab, followed by cetuximab as single-agent therapy for unresectable squamous cell carcinoma of the skin: a case report

Conclusion:
The treatment was effective and feasible. Considering these excellent results, further studies about concomitant tomotherapy with Cetuximab for advanced/inoperable SCC of the skin are needed.

Source: BMC Dermatology - September 30, 2014 Category: Dermatology Authors: Sara FaliveneFrancesca GiuglianoAntonio GrimaldiRossella Di FrancoDiego ToledoMatteo MutoFabrizio CammarotaValentina BorzilloPaolo AsciertoPaolo Muto Source Type: research